Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04987138 · ClinicalTrials.gov registry record · NA
Safety and Effectiveness Study of the Zenflow Spring System
A NA study of BPH (Benign Prostatic Hyperplasia) and Lower Urinary Tract Symptoms (LUTS), sponsored by Zenflow.
- Active
- Registry status
- NA
- Development phase
- 279
- Enrollment target
- 7
- Study locations
NCT04987138: Active NA study of BPH (Benign Prostatic Hyperplasia) and Lower Urinary Tract Symptoms (LUTS), sponsored by Zenflow.
NCT04987138 is a NA study of BPH (Benign Prostatic Hyperplasia) and Lower Urinary Tract Symptoms (LUTS) that is active but no longer recruiting, run by Zenflow. The registered enrollment target is 279 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (80% lower). The trial reports 7 study locations across 6 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04987138, a NA study of BPH (Benign Prostatic Hyperplasia) and Lower Urinary Tract Symptoms (LUTS), is active but no longer recruiting, sponsored by Zenflow.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 279 participants
- Enrollment target
- 7
- Study locations
Study Summary
Evaluate the safety and effectiveness of the Zenflow Spring System in relieving LUTS associated with BPH.
Conditions Studied
Interventions
- DEVICE Sham Procedure
- DEVICE Zenflow Spring System
Study Locations (7)
Texas
- Midtown Urology Associates - Austin
- Urology Austin, PLLC - Austin
California
- American Institute of Research - Los Angeles
Illinois
- Northshore University Health System - Glenview
Nevada
- Sheldon Freedman, MD, LTD - Las Vegas
South Carolina
- Carolina Urologic Research Associates - Myrtle Beach
Virginia
- Urology of Virginia, PLLC - Virginia Beach
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 279 participants |
| Start Date | 2021-09-30 |
| Est. Completion | 2026-06 |
| Phase | NA |
What the registry record for NCT04987138 still lists
NCT04987138 is an interventional study that assigns participants to a tested intervention. The registered 279 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (80% lower).
The record links to 2 conditions, with BPH (Benign Prostatic Hyperplasia) appearing as the primary indexed condition, and to 2 interventions - of which Sham Procedure is the first listed.
NCT04987138 lists 7 locations in 6 states (Texas, California, Illinois).
Frequently Asked Questions
What is clinical trial NCT04987138 about?
NCT04987138 is a clinical study titled "Safety and Effectiveness Study of the Zenflow Spring System". Evaluate the safety and effectiveness of the Zenflow Spring System in relieving LUTS associated with BPH.
What is the current status of trial NCT04987138?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 279 participants. The study started on 2021-09-30. Estimated completion is 2026-06.
What conditions does trial NCT04987138 study?
This clinical trial studies the following conditions: BPH (Benign Prostatic Hyperplasia), Lower Urinary Tract Symptoms (LUTS).
What interventions are being tested in trial NCT04987138?
The interventions under investigation include: Sham Procedure (DEVICE), Zenflow Spring System (DEVICE).
Who is sponsoring clinical trial NCT04987138?
This trial is sponsored by Zenflow, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04987138 being conducted?
This trial has 7 study locations across California, Illinois, Nevada, South Carolina, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for BPH (Benign Prostatic Hyperplasia)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04987138's enrollment target sits among peer trials
279 381st of 2000 higher than 1,619 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04783857 · 279 participants · Phase 4
Modifying Progesterone and Estradiol Levels to Prevent Postpartum Cigarette Smoking Relapse and Reduce Secondhand Smoke Exposure in Infants and Children
- NCT05407324 · 279 participants · Phase 2
Dazucorilant in Patients With Amyotrophic Lateral Sclerosis
- NCT06299748 · 279 participants
A Worldwide Pregnancy Safety Study to Assess Maternal, Fetal, and Infant Outcomes Following Exposure to Efgartigimod During Pregnancy and/or Breastfeeding.
- NCT06582784 · 279 participants · NA
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI